The Global Dementia Drugs Market is Expected to Register Immense Growth at a CAGR of 8.42% by 2027 | DelveInsight
02 juin 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, June 02, 2022 (GLOBE NEWSWIRE) -- The Global Dementia Drugs Market is Expected to Register Immense Growth at a CAGR of 8.42% by 2027 | DelveInsight The dementia drugs market is...
Alzheimer's Patient Advocates Launch Free Courses Promoting Brain Health
26 mai 2022 14h37 HE
|
UsAgainstAlzheimer's
Washington, D.C., May 26, 2022 (GLOBE NEWSWIRE) -- Today UsAgainstAlzheimer’s announced the launch of The Brain Health Academy (BHA), a new series of free online courses designed in partnership with...
Frontotemporal Dementia Pipeline Landscape Analysis of 20+ Companies by DelveInsight
07 mars 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, March 07, 2022 (GLOBE NEWSWIRE) -- Frontotemporal Dementia Pipeline Landscape Analysis of 20+ Companies by DelveInsight With the increasing numbers of promising treatments...
Global Alzheimer's Disease Therapeutics & Diagnostics Market 2021-2028 - Emerging Novel Diagnostic Technologies Presents Lucrative Opportunities for Players
04 févr. 2022 05h18 HE
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Disease Therapeutics and Diagnostics Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global...
Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase 2 Clinical Trial of ATH-1017 for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
25 janv. 2022 07h00 HE
|
Athira Pharma, Inc.
BOTHELL, Wash., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Lui Franciosi To Assess the Safety and Efficacy of a New Dementia Treatment
05 janv. 2022 16h00 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing and monitoring the safety and efficacy of the new...
LiveFreely Announces Apple Watch Version of 'BUDDY,' the Predictive AI-Driven Digital Health Assistant for Seniors and Their Loved Ones
22 déc. 2021 09h00 HE
|
LiveFreely Inc
SAN JOSE, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- LiveFreely, Inc., a Silicon Valley digital health company that develops innovative technology to improve the health and well-being of seniors and...
ADM Diagnostics, Inc. Announces Launch of CorInsights® MRI
14 déc. 2021 10h00 HE
|
ADM Diagnostics Inc
NORTHBROOK, Ill., Dec. 14, 2021 (GLOBE NEWSWIRE) -- ADM Diagnostics, Inc. (ADMdx) has received FDA clearance for CorInsights MRI. Using a standard MRI scan, CorInsights MRI provides quantitative...
Improving Social Equity in Dementia Prevention and Care
30 nov. 2021 08h00 HE
|
Posit Science
WASHINGTON, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Jeff Zimman, Co-Founder of Posit Science, which makes the brain training app BrainHQ, will address the annual What’s Next Longevity Innovation Summit in...
The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis
27 oct. 2021 07h45 HE
|
Roots Analysis
London, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list of offerings. Limited treatment...